Abstract
Previous studies have shown that the late-onset and cryptic forms of 21-hydroxylase deficiency are highly associated with the HLA supratype HLA-B14,C4A2,C4B1/2,DR1. Since cells from a number of unrelated normal individuals from different ethnic backgrounds expressing the DR1 associated with this supratype failed to stimulate two different DR1-restricted T-cell clones that proliferated in the presence of most other DR1 cells, we decided to test the hypothesis that cells with this supratype express "abnormal" DR1 molecules that have been affected in some way by the chromosomal mutation responsible for B14,DR1-associated 21-hydroxylase deficiency (21-OH-defL). The results showed an association between "abnormal" DR1 and 21-OH-defL (elevated rates of 17 alpha-hydroxyprogesterone [17-OHP] increase and elevated peak 17-OHP values following ACTH stimulation). The presence of the B14,DR1 supratype can be used to predict the presence of "abnormal" DR1 and the clinical status of individuals not previously known to be 21-OH-defL carriers.
Full text
PDF










Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Awdeh Z. L., Alper C. A. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3576–3580. doi: 10.1073/pnas.77.6.3576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Awdeh Z. L., Raum D., Yunis E. J., Alper C. A. Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. Proc Natl Acad Sci U S A. 1983 Jan;80(1):259–263. doi: 10.1073/pnas.80.1.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bach F. H., Anichini A., Reinsmoen N., Groner J., Watson A., Segall M. Genetic and molecular analyses of lymphocyte-defined HLA-D region specificities. Hum Immunol. 1983 Sep;8(1):25–32. doi: 10.1016/0198-8859(83)90078-2. [DOI] [PubMed] [Google Scholar]
- Biddison W. E., Krangel M. S., Strominger J. L., Ward F. E., Shearer G. M., Shaw S. Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules. Hum Immunol. 1980 Oct;1(3):225–232. doi: 10.1016/0198-8859(80)90017-8. [DOI] [PubMed] [Google Scholar]
- Blankstein J., Faiman C., Reyes F. I., Schroeder M. L., Winter J. S. Adult-onset familial adrenal 21-hydroxylase deficiency. Am J Med. 1980 Mar;68(3):441–448. doi: 10.1016/0002-9343(80)90117-5. [DOI] [PubMed] [Google Scholar]
- Breuning M. H., Spits H., de Vries J. E., Iványi P. A cloned cytotoxic T-lymphocyte (CTL) line recognizing a subtype of HLA B27. Hum Immunol. 1984 Apr;9(4):231–242. doi: 10.1016/0198-8859(84)90028-4. [DOI] [PubMed] [Google Scholar]
- Carroll M. C., Campbell R. D., Porter R. R. Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci U S A. 1985 Jan;82(2):521–525. doi: 10.1073/pnas.82.2.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Christiansen F. T., Dawkins R. L., Uko G., McCluskey J., Kay P. H., Zilko P. J. Complement allotyping in SLE: association with C4A null. Aust N Z J Med. 1983 Oct;13(5):483–488. doi: 10.1111/j.1445-5994.1983.tb02699.x. [DOI] [PubMed] [Google Scholar]
- Cobain T. J., Stuckey M. S., McCluskey J., Wilton A. N., Gedeon A., Garlepp M. J., Christiansen F. T., Dawkins R. L. The coexistence of IgA deficiency and 21-hydroxylase deficiency marked by specific MHC supratypes. Ann N Y Acad Sci. 1985;458:76–84. doi: 10.1111/j.1749-6632.1985.tb14593.x. [DOI] [PubMed] [Google Scholar]
- Couillin P., Rappaport R., Kuttenn F., Canlorbe P., Hors J., Marcelli-Barge A., Feingold J., Grisard M. C., Boué J., Boué A. HLA and 21 hydroxylase deficiency (congenital and late onset adrenal hyperplasia) in the French population. Tissue Antigens. 1982 Feb;19(2):100–107. doi: 10.1111/j.1399-0039.1982.tb01424.x. [DOI] [PubMed] [Google Scholar]
- Dawkins R. L., Christiansen F. T., Kay P. H., Garlepp M., McCluskey J., Hollingsworth P. N., Zilko P. J. Disease associations with complotypes, supratypes and haplotypes. Immunol Rev. 1983;70:5–22. doi: 10.1111/j.1600-065x.1983.tb00707.x. [DOI] [PubMed] [Google Scholar]
- Gotch F. M., Kelly C., Ellis S. A., Wallace L., Rickinson A. B., van der Poel J., Crumpton M. J., McMichael A. J. Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity. Immunogenetics. 1985;21(1):11–23. doi: 10.1007/BF00372237. [DOI] [PubMed] [Google Scholar]
- Hanke J. H., Brown M. F., Pollack M. S., Rich R. R. Class II determinants recognized by TNP-specific cloned human T cell lines. Hum Immunol. 1985 Sep;14(1):59–76. doi: 10.1016/0198-8859(85)90065-5. [DOI] [PubMed] [Google Scholar]
- Höller W., Scholz S., Knorr D., Bidlingmaier F., Keller E., Albert E. D. Genetic differences between the salt-wasting, simple virilizing, and nonclassical types of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1985 Apr;60(4):757–763. doi: 10.1210/jcem-60-4-757. [DOI] [PubMed] [Google Scholar]
- Kohn B., Levine L. S., Pollack M. S., Pang S., Lorenzen F., Levy D., Lerner A. J., Rondanini G. F., Dupont B., New M. I. Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1982 Nov;55(5):817–827. doi: 10.1210/jcem-55-5-817. [DOI] [PubMed] [Google Scholar]
- Laron Z., Pollack M. S., Zamir R., Roitman A., Dickerman Z., Levine L. S., Lorenzen F., O'Neill G. J., Pang S., New M. I. Late onset 21-hydroxylase deficiency and HLA in the Ashkenazi population: a new allele at the 21-hydroxylase locus. Hum Immunol. 1980 Jul;1(1):55–66. doi: 10.1016/0198-8859(80)90009-9. [DOI] [PubMed] [Google Scholar]
- Levine L. S., Dupont B., Lorenzen F., Pang S., Pollack M., Oberfield S. E., Kohn B., Lerner A., Cacciari E., Mantero F. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1981 Dec;53(6):1193–1198. doi: 10.1210/jcem-53-6-1193. [DOI] [PubMed] [Google Scholar]
- Libber S. M., Migeon C. J., Bias W. B. Ascertainment of 21-hydroxylase deficiency in individuals with HLA-B14 haplotype. J Clin Endocrinol Metab. 1985 Apr;60(4):727–730. doi: 10.1210/jcem-60-4-727. [DOI] [PubMed] [Google Scholar]
- Menninger R. P. Current concepts of volume receptor regulation of vasopressin release. Fed Proc. 1985 Jan;44(1 Pt 1):55–58. [PubMed] [Google Scholar]
- Migeon C. J., Rosenwaks Z., Lee P. A., Urban M. D., Bias W. B. The attenuated form of congenital adrenal hyperplasia as an allelic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1980 Sep;51(3):647–649. doi: 10.1210/jcem-51-3-647. [DOI] [PubMed] [Google Scholar]
- New M. I., Lorenzen F., Lerner A. J., Kohn B., Oberfield S. E., Pollack M. S., Dupont B., Stoner E., Levy D. J., Pang S. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab. 1983 Aug;57(2):320–326. doi: 10.1210/jcem-57-2-320. [DOI] [PubMed] [Google Scholar]
- Pollack M. S., Levine L. S., O'Neill G. J., Pang S., Lorenzen F., Kohn B., Rondanini G. F., Chiumello G., New M. I., Dupont B. HLA linkage and B14, DR1, BfS haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency. Am J Hum Genet. 1981 Jul;33(4):540–550. [PMC free article] [PubMed] [Google Scholar]
- White P. C., New M. I., Dupont B. HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci U S A. 1984 Dec;81(23):7505–7509. doi: 10.1073/pnas.81.23.7505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilton A. N., Cobain T. J., Dawkins R. L. Family studies of IgA deficiency. Immunogenetics. 1985;21(4):333–342. doi: 10.1007/BF00430799. [DOI] [PubMed] [Google Scholar]
